SYNSERIN

SyneuRx International (Taiwan) Corp

Application Filed: 2018-06-07

Trademark Application Details

Status

688

Live/Pending

NOTICE OF ALLOWANCE - ISSUED

Research	OneLook Acronym Finder
Serial Number	87953269
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Joe McKinney Muncy
Attorney Docket Number	5454/0191TUS
Law Office Assigned	L90
Employee Name	RATCLIFFE, ROBERT L

Timeline

2018-06-07	Application Filed
2018-11-13	Published for Opposition
2019-01-08	Location: INTENT TO USE SECTION
2019-01-08	Status: Live/Pending
2019-01-08	Transaction Date
2019-12-16	Trademark Registered

Trademark Applicants & Owners

Owner:	SyneuRx International (Taiwan) Corp
Address	20F.-10, No.99, Sec. 1 Xintai 5th Rd., Xizhi Dist New Taipei City TW 221
Legal Entity Type	Corporation
Legal Entity State	TW

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

JOE MCKINNEY MUNCY
MUNCY, GEISSLER, OLDS & LOWE, P.C.
4000 LEGATO ROAD
SUITE 310
FAIRFAX, VA 22033

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical reagents for medical or veterinary purposes; Antibacterial substances for medical purposes; Amino acid preparations for medical purposes; Amino acids for medical or veterinary purposes; Amino acids for medical purposes
GS0051	Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical reagents for medical or veterinary purposes; Antibacterial substances for medical purposes; Amino acid preparations for medical purposes; Amino acids for medical or veterinary purposes; Amino acids for medical purposes

Type Code

Type

GS0051

Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical reagents for medical or veterinary purposes; Antibacterial substances for medical purposes; Amino acid preparations for medical purposes; Amino acids for medical or veterinary purposes; Amino acids for medical purposes

GS0051

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2018-06-11	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2018-06-14	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2018-09-25	3 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER	2018-10-02	4 CNSA P:
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2018-10-24	5 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2018-11-13	6 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2018-11-13	7 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2019-01-08	8 NOAM E:E-Mail
TEAS EXTENSION RECEIVED	2019-06-13	9 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2019-06-13	10 EXT1 S:
EXTENSION 1 GRANTED	2019-06-13	11 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2019-06-15	12 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2019-12-13	13 EEXT I:Incoming Correspondence
EXTENSION 2 FILED	2019-12-13	14 EXT2 S:
EXTENSION 2 GRANTED	2019-12-13	15 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2019-12-17	16 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2020-06-10	17 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2020-06-10	18 EXT3 S:
EXTENSION 3 GRANTED	2020-06-10	19 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2020-06-12	20 EXRA E:E-Mail
TEAS CHANGE OF OWNER ADDRESS RECEIVED	2020-07-24	21 COAR I:Incoming Correspondence
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	2020-07-24	22 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	2020-07-24	23 ARAA I:Incoming Correspondence
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS	2020-07-24	24 ECDR I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2020-07-24	25 TCCA I:Incoming Correspondence
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED	2020-07-24	26 CHAN I:Incoming Correspondence
TEAS PETITION TO AMEND BASIS RECEIVED	2020-10-01	27 TPAD I:Incoming Correspondence
ASSIGNED TO PETITION STAFF	2020-12-01	28 APET A:Allowance for Publication
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED	2020-12-02	29 PCBG O:Outgoing Correspondence
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED	2020-12-02	30 ATRQ I:Incoming Correspondence
NOTICE OF ALLOWANCE CANCELLED	2020-12-09	31 IUCN S:
CASE RETURNED TO EXAMINATION	2020-12-09	32 OTHE I:Incoming Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2020-12-23	33 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2021-01-12	34 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2021-01-12	35 NPUB E:E-Mail
REGISTERED-PRINCIPAL REGISTER	2021-03-30	36 R.PR A:Allowance for Publication

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.